Huma receives 510(k) Class II FDA clearance for disease-agnostic platform
Clinical Trial Technology
Jun 13, 2023
M&A
Huma Therapeutics acquires Alcedis to expand clinical trial support
Clinical Trial Technology
Jan 10, 2023
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.